Table 5.

Multivariate analysis of the classification tree risk groups and EMR status at 3 months

MMRMR4MR4.5FFS
RRPRRPRRPHRP
Classification tree baseline risk group         
 Favorable 1  1  1  1  
 Low 0.77 .13 0.74 .2 0.55 .012 1.89 .062 
 High 0.62 .011 0.68 .11 0.43 .002 2.34 .021 
 Ultra-high 0.41 <.001 0.29 .001 0.21 .002 2.86 .005 
EMR status at 3 months of imatinib treatment, %         
 ≤10 1  1  1  1  
 >10 0.21 <.001 0.16 <.001 0.09 <.001 1.53 <.001 
MMRMR4MR4.5FFS
RRPRRPRRPHRP
Classification tree baseline risk group         
 Favorable 1  1  1  1  
 Low 0.77 .13 0.74 .2 0.55 .012 1.89 .062 
 High 0.62 .011 0.68 .11 0.43 .002 2.34 .021 
 Ultra-high 0.41 <.001 0.29 .001 0.21 .002 2.86 .005 
EMR status at 3 months of imatinib treatment, %         
 ≤10 1  1  1  1  
 >10 0.21 <.001 0.16 <.001 0.09 <.001 1.53 <.001 

Relative risks and hazard ratios for the classification tree are compared with the favorable-risk group.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal